Good Publication Practice for Pharmaceutical Companies
- Topics:
- Pharmeceuticals
- Tags:
- Healthcare,
- LibraPharm,
- Publication
- Source:
- LibraPharm
FREE Registration is required
Overview: Drug companies have sometimes been criticized for their methods of developing publications as well as for their failure to publish unfavorable findings. The GPP guidelines call on companies to endeavor to publish results of all their clinical trials of marketed products. They also recommend practical steps to reduce publication bias and redundant publication. One unique feature, not covered by guidelines from journal editors, is that they address the role of professional medical writers and, especially, writers' interactions with authors.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 520KB | Date: May 2003 | Pages: 12




